News

CIDRAP8h
Quick takes: EMA lifts chikungunya vaccine restriction, Nipah in India, expanded review for RSV vaccine
Testing at India’s National Institute of Virology has confirmed a third recent Nipah virus case from India’s Kerla state, ...
WHO Extended Global Emergency Status of MPox Epidemic – Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
Pulmonology Advisor15h
Multicomponent Vaccine for COVID-19, Influenza Shows Promise in Phase 3 Trial
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
European Medical Journal14h
Lack of Rigorous Clinical Data Risks Efficacy Decline in Influenza Vaccines
New analysis warns that suboptimal clinical trial designs and overreliance on surrogate markers may allow less effective flu ...
IFLScience on MSN12h
Yet More Evidence That Getting Your Seasonal Flu Shot Protects You And Others Around You
“In our results, a substantial proportion of infections was prevented when transmissibility was similar to that encountered in typical influenza seasons, vaccine effectiveness was within the ranges ...
Verywell Health on MSN10h
RFK Jr.'s Vaccine Panel Wants to Remove Thimerosal From Flu Shots. Is It Actually Toxic?
Decades of research show the mercury-containing preservative thimerosal is safe in vaccines, but CDC's new advisory panel is ...